Literature DB >> 7804062

ABC of breast diseases. Metastatic breast cancer.

R C Leonard1, A Rodger, J M Dixon.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7804062      PMCID： PMC2541626          DOI： 10.1136/bmj.309.6967.1501

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.

Authors:  M J Page; B Amess; R R Townsend; R Parekh; A Herath; L Brusten; M J Zvelebil; R C Stein; M D Waterfield; S C Davies; M J O'Hare
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Mouth care and skin care in palliative medicine. Chlorhexidine mouth washes are important in mouth care.

Authors:  V S Lucas; G J Roberts
Journal:  BMJ       Date:  1998-04-18

3.  Breast cancer presenting as parotid tumour - first reported case in literature.

Authors:  Rakesh S Ramesh; Suraj Manjunath; Tanveer Hussain Ustad; Saira Pais; K Shivakumar
Journal:  Indian J Surg Oncol       Date:  2010-08-07

4.  Cost effectiveness of letrozole in the treatment of advanced breast cancer in postmenopausal women in the UK.

Authors:  M Nuijten; L Meester; F Waibel; S Wait
Journal:  Pharmacoeconomics       Date:  1999-10       Impact factor: 4.981

5.  Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.

Authors:  Jonathan Karnon; Jackie Brown
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 6.  Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer.

Authors:  L R Wiseman; K L Goa
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

Review 7.  Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancer.

Authors:  L R Wiseman; J C Adkins
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

8.  A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patients.

Authors:  Jon Karnon; Trefor Jones
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial.

Authors:  M Spielmann; M Tubiana-Hulin; M Namer; H Mansouri; P h Bougnoux; N Tubiana-Mathieu; V Lotz; J C Eymard
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

Review 10.  Curative use of forequarter amputation for recurrent breast cancer over an axillary area: a case report and literature review.

Authors:  Chun-Hao Tsai; Huey-En Tzeng; Wei-Kae Juang; Pei-Guo Chu; Patricia Fann; Yi-Chin Fong; Horng-Chaung Hsu; Yun Yen
Journal:  World J Surg Oncol       Date:  2014-11-18       Impact factor: 2.754
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.